Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BARK NYSE:DAL NASDAQ:PPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBARKBARK$9.31-7.2%$9.37$8.15▼$22.60$81.79M1.9380,802 shs13,772 shsDALDelta Air Lines$86.38+2.6%$74.69$45.28▼$87.39$56.76B1.39.92 million shs3.44 million shsPPHVanEck Pharmaceutical ETF$103.65+1.1%$103.03$81.74▼$112.58$983.64M0.47334,869 shs157,652 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBARKBARK0.00%+1.68%+14.84%-20.24%-38.38%DALDelta Air Lines0.00%+1.27%+10.51%+29.10%+78.16%PPHVanEck Pharmaceutical ETF0.00%-3.70%-2.34%+1.59%+17.57%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBARKBARK$9.31-7.2%$9.37$8.15▼$22.60$81.79M1.9380,802 shs13,772 shsDALDelta Air Lines$86.38+2.6%$74.69$45.28▼$87.39$56.76B1.39.92 million shs3.44 million shsPPHVanEck Pharmaceutical ETF$103.65+1.1%$103.03$81.74▼$112.58$983.64M0.47334,869 shs157,652 shs7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBARKBARK0.00%+1.68%+14.84%-20.24%-38.38%DALDelta Air Lines0.00%+1.27%+10.51%+29.10%+78.16%PPHVanEck Pharmaceutical ETF0.00%-3.70%-2.34%+1.59%+17.57%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBARKBARK 2.20Hold$15.3357.59% UpsideDALDelta Air Lines 2.96Moderate Buy$81.05-4.49% DownsidePPHVanEck Pharmaceutical ETF 2.63Moderate Buy$102.53N/ACurrent Analyst Ratings BreakdownLatest DAL, PPH, EZH, BARK, and SSTY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/22/2026DALDelta Air Lines ArgusSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$85.00 ➝ $100.006/17/2026DALDelta Air Lines Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$88.00 ➝ $93.006/11/2026BARKBARK Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$19.006/10/2026BARKBARK Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$30.00 ➝ $12.006/1/2026DALDelta Air Lines Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$90.00 ➝ $105.005/27/2026DALDelta Air Lines TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$84.00 ➝ $92.005/26/2026DALDelta Air Lines UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$95.00 ➝ $98.005/11/2026DALDelta Air Lines Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$81.00 ➝ $88.005/11/2026DALDelta Air Lines Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$81.00 ➝ $88.005/7/2026DALDelta Air Lines UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$86.00 ➝ $95.005/6/2026BARKBARK Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)(Data available from 6/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBARKBARK$394.84M0.22N/AN/A$8.33 per share1.17DALDelta Air Lines$63.36B0.88$9.64 per share8.80$31.94 per share2.66PPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBARKBARK-$39.01M-$3.60N/A8.11N/A-9.88%-42.27%-16.28%8/6/2026 (Estimated)DALDelta Air Lines$5.01B$6.8612.3811.241.166.87%20.28%4.85%7/9/2026 (Estimated)PPHVanEck Pharmaceutical ETFN/AN/A20.21N/AN/AN/AN/AN/AN/ALatest DAL, PPH, EZH, BARK, and SSTY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/9/2026Q2 2026DALDelta Air Lines$1.49N/AN/AN/A$17.43 billionN/A6/9/2026Q4 2026BARKBARK-$0.3467$0.07+$0.4167-$1.57$96.30 million$86.57 million4/8/2026Q1 2026DALDelta Air Lines$0.61$0.64+$0.03-$0.44$14.05 billion$14.20 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBARKBARKN/AN/AN/AN/AN/ADALDelta Air Lines$0.750.88%+11.20%10.93%1 YearsPPHVanEck Pharmaceutical ETF$2.152.10%N/AN/AN/ALatest DAL, PPH, EZH, BARK, and SSTY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/18/2026DALDelta Air Linesquarterly$0.21501.02%7/9/20267/9/20267/30/20264/15/2026DALDelta Air Linesquarterly$0.18751.05%5/14/20265/14/20266/4/20263/31/2026PPHVanEck Pharmaceutical ETFQuarterly$0.84413.23%4/1/20264/1/20264/7/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBARKBARKN/A1.860.71DALDelta Air Lines0.540.420.36PPHVanEck Pharmaceutical ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBARKBARK28.76%DALDelta Air Lines69.93%PPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipBARKBARK14.80%DALDelta Air Lines0.80%PPHVanEck Pharmaceutical ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBARKBARK6408.79 million7.49 millionOptionableDALDelta Air Lines100,000656.99 million651.74 millionOptionablePPHVanEck Pharmaceutical ETF147,0009.49 millionN/AOptionableDAL, PPH, EZH, BARK, and SSTY HeadlinesRecent News About These CompaniesHealthcare ETFs: From Broad Exposure to Big BreakthroughsJune 11, 2026 | etftrends.comEInside the GLP-1 Boom: ETF Picks for the Obesity Drug MarketJune 10, 2026 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?June 5, 2026 | zacks.comUS FDA to review AI-based tool to predict drug-related liver damageJune 3, 2026 | reuters.comAdding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns.June 2, 2026 | fool.comPPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare EcosystemMay 27, 2026 | finance.yahoo.comDitch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices?May 19, 2026 | 247wallst.comShould You Invest in the Invesco Pharmaceuticals ETF (PJP)?April 29, 2026 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?April 2, 2026 | zacks.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.8441April 1, 2026 | msn.comPPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026March 28, 2026 | 247wallst.comBig Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And MoreFebruary 7, 2026 | seekingalpha.comHealthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales OutlookFebruary 4, 2026 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?January 28, 2026 | zacks.comVanEck Pharmaceutical ETF $PPH Shares Sold by Adamsbrown Wealth Consultants LLCJanuary 28, 2026 | defenseworld.netDVanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 BillionJanuary 23, 2026 | 247wallst.comNovo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In FocusDecember 23, 2025 | benzinga.comWhy PPH Keeps Working When Single Themes BreakDecember 17, 2025 | seekingalpha.comDay by day downgrades VanEck ETF Trust - VanEck Pharmaceutical ETF (PPH)December 16, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?November 27, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 20263 Stocks to Watch If the Strait of Hormuz ReopensBy Chris Markoch | June 17, 2026Macy's Delivers Strong Q1, Raises Outlook, but Wall Street Remains CautiousBy Jennifer Ryan Woods | June 5, 2026PPH, DAL, EZH, BARK, and SSTY Company DescriptionsBARK NYSE:BARK$9.30 -0.73 (-7.23%) As of 02:35 PM Eastern This is a fair market value price provided by Massive. Learn more.BARK Inc., a dog-centric company, provides products, services, and content for dogs. It operates in two segments, Direct to Consumer and Commerce. The company serves dogs through monthly subscription services. It is also involved in the design of playstyle-specific toys, satisfying treats, personal meal plans with supplements, and dog-first experiences designed to foster health and happiness of dogs everywhere. In addition, the company offers monthly themed box of toys and treats under the BarkBox and Super Chewer names; personalized meal plans under the BARK Food name; health and wellness products under the BARK Bright name; and dog beds, bowls, collars, harnesses, and leashes under the BARK Home brand. Further, the company sells BARK Home products through BarkShop.com. Additionally, it offers custom collections through online marketplaces, and brick and mortar retailers. The company was formerly known as The Original BARK Company and changed its name to BARK, Inc. in November 2021. BARK Inc. was incorporated in 2011 and is headquartered in New York, New York.Delta Air Lines NYSE:DAL$86.36 +2.18 (+2.59%) As of 02:36 PM Eastern This is a fair market value price provided by Massive. Learn more.Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.VanEck Pharmaceutical ETF NASDAQ:PPH$103.70 +1.17 (+1.14%) As of 02:21 PM EasternThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas USA Today's Digital Revival Is Gaining Steam, But With Plenty of Risk Burlington Is Winning Over Shoppers But Investors Need Patience Investors Are Buying Into Sweetgreen Again—Should They? MarketBeat Week in Review – 06/15 - 06/19 Cheesecake Factory Stock Is Up Over 50%—Is There Room for More CAKE? Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally? Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
